LXEO
NASDAQ · Biotechnology
Lexeo Therapeutics Inc
$4.81
+0.26 (+5.71%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+866.1% upside
Low Target
$27.16
Average Target
$46.47
High Target
$57.70
Current Price
$4.81
Current
$4.81
$4.81
Target
$46.47
$46.47
$27.16
$46.47 avg
$57.70
Scenario Analysis
Bear Case
$27.16
464.7%
Low target
Base Case
$46.47
+866.1%
Avg target
Bull Case
$57.70
+1,099.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$10.99
-56.2% from high
52-Week Low
$3.99
+20.6% from low
Target vs 52W High
$46.47
+322.8% vs high
Next Earnings Report
Aug 19, 2026
9d
until earnings
EPS Est: $-0.29
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |